LSTM-assisted machine learning framework for low-data prioritization of CepI-targeted candidates: a focus on Burkholderia cenocepacia
Frontiers in Cellular and Infection Microbiology · 18.11.2026 · 16
DOI: 10.3389/fcimb.2026.1934561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 18.11.2026. Verfasst von Vijayavidhya Magizhvannan und 1 weiteren Autor:innen. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Antimicrobial resistance poses a substantial threat to global healthcare particularly in immunocompromised individuals. Burkholderia cenocepacia is a clinically important opportunistic bacterium responsible for persistent respiratory infections in cystic fibrosis patients. Its intrinsic antimicrobial resistance and ability to form biofilms make conventional treatment ineffective. Therefore, targeting virulence-associated quorum sensing pathway represents an alternative anti-virulence strategy to reduce pathogenicity without directly imposing bactericidal pressure. Importantly, CepI , an autoinducer synthase involved in acyl-homoserine lactone biosynthesis, serves as a promising molecular target for disrupting quorum sensing mediated pathogenicity.
Methods
The present study combines randomized-SMILES augmentation, LSTM-based molecular generation, machine-learning-aided drug repurposing and structure-based validation to identify potential CepI -targeting candidates. Model robustness was evaluated using scaffold-aware, y-randomization, provenance-control and cross-provenance. The optimized model was applied to the DrugBank library, followed by applicability-domain assessment using Mahalanobis distance, k-nearest-neighbor analysis and principal component analysis. Prioritized candidates were further evaluated by docking, MM-GBSA, ADMET analysis and triplicate molecular dynamics simulations. Results and discussion Among the evaluated classifiers, the Extra Trees model showed the best 10-fold cross-validation performance, with a ROC-AUC of 0.992 ± 0.025. In contrast, 100-iteration Y-randomization produced a mean ROC-AUC of 0.481 ± 0.084 (maximum = 0.559), compared with 0.99 for the original model (p = 0.0099). The near-chance performance under randomized labels provided evidence against a simple chance-label explanation. Provenance-control analyses indicated that the classification signal was not explained solely by a simple literature-versus-LSTM source label, although residual provenance and chemical-space bias cannot be completely excluded. Integration of the activity-probability threshold and applicability-domain criteria narrowed the DrugBank screening set to 115 compounds for structure-based analysis. Among these, DB12364 (betrixaban) was prioritized based on its predicted activity, applicability-domain assessment, docking, MM-GBSA and molecular dynamics results, and is proposed as a computationally prioritized candidate for experimental evaluation as a potential CepI -targeting compound against B. cenocepacia .
Zitieren
APA
Magizhvannan, V., & Veerappapillai, S. (2026). LSTM-assisted machine learning framework for low-data prioritization of CepI-targeted candidates: a focus on Burkholderia cenocepacia. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1934561
Vancouver
Magizhvannan V, Veerappapillai S. LSTM-assisted machine learning framework for low-data prioritization of CepI-targeted candidates: a focus on Burkholderia cenocepacia. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1934561
BibTeX
@article{Magizhvannan2026,
author = {Magizhvannan, Vijayavidhya and Veerappapillai, Shanthi},
title = {LSTM-assisted machine learning framework for low-data prioritization of CepI-targeted candidates: a focus on Burkholderia cenocepacia},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1934561}
}
EUVIMED